ClearPoint Neuro, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ClearPoint Neuro, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $28.00K.
- ClearPoint Neuro, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-03-31 was $21.00K.
- ClearPoint Neuro, Inc. stock issued during period, value, stock options exercised for the quarter ending 2022-09-30 was $7.00K.
- ClearPoint Neuro, Inc. stock issued during period, value, stock options exercised for the quarter ending 2019-09-30 was $4.35K.
- ClearPoint Neuro, Inc. stock issued during period, value, stock options exercised for fiscal 2020 was $376.00K, a 3.34% decline from fiscal 2019.
- ClearPoint Neuro, Inc. stock issued during period, value, stock options exercised for fiscal 2019 was $389.00K.
- ClearPoint Neuro, Inc. stock issued during period, value, stock options exercised for fiscal 2014 was $143.00K, a 628.66% increase from fiscal 2013.
- ClearPoint Neuro, Inc. stock issued during period, value, stock options exercised for fiscal 2013 was $19.63K, a 79.20% decline from fiscal 2012.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-06-30 | $28.00K 10-Q · filed 2025-11-06 | |
| 2024-03-31 | $21.00K 10-Q · filed 2025-11-06 | |
| 2022-09-30 | $7.00K 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $376.00K 10-K · filed 2022-03-09 | |
| 2019-12-31 | $389.00K 10-K · filed 2021-03-22 | |
| 2019-09-30 | $4.35K 10-Q · filed 2020-11-12 | |
| 2014-12-31 | $143.00K 10-K · filed 2016-03-25 | |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $19.63K 10-K · filed 2014-03-28 |
| 2013-09-30 | $6.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | |
| 2012-12-31 | $93.75K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $94.35K 10-K · filed 2014-03-28 |
| 2011-12-31 | $2.25K 10-K/A · filed 2013-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |